CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- Open-market buys, last 90 days
- $23,756
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-26 | Barrage Khalil Director | Grant or award · PTIX Common stock NSO Options | +180,000 | 180,000 | ||
| 2021-05-18 | Arrow Alexander K. Chief Financial Officer | Purchase · PTIXW Common Stock 5-year warrants strike price $4.98 | +12,000 | $0.32 | $4K | 12,000 |
| 2021-05-18 | Arrow Alexander K. Chief Financial Officer | Purchase · PTIXW Common Stock 5-year warrants strike price $4.98 | +18,000 | $0.31 | $6K | 30,000 |
| 2021-05-03 | Barrage Khalil Director | Option exercise | +45,000 | $1.25 | $56K | 95,000 |
| 2021-05-03 | Barrage Khalil Director | Option exercise | +150,000 | $1.25 | $188K | 245,000 |
| 2021-05-03 | Barrage Khalil Director | Option exercise | +45,000 | $1.75 | $79K | 290,000 |
| 2021-05-03 | Barrage Khalil Director | Option exercise | +120,000 | $1.75 | $210K | 410,000 |
| 2021-05-03 | Barrage Khalil Director | Option exercise · PTIX Common stock Options | −45,000 | 315,000 | ||
| 2021-05-03 | Barrage Khalil Director | Option exercise · PTIX Common stock Options | −150,000 | 165,000 | ||
| 2021-05-03 | Barrage Khalil Director | Option exercise · PTIX Common stock Options | −45,000 | 120,000 | ||
| 2021-05-03 | Barrage Khalil Director | Option exercise · PTIX Common stock Options | −120,000 | 0 | ||
| 2021-04-30 | Arrow Alexander K. Chief Financial Officer | Purchase | +1,000 | $2.29 | $2K | 120,260 |
| 2021-04-29 | Arrow Alexander K. Chief Financial Officer | Purchase | +1,000 | $2.29 | $2K | 119,260 |
| 2020-07-18 | Buell Jennifer Director | Grant or award · PTIX Common stock Options | +145,000 | $1.75 | $254K | 145,000 |
| 2020-07-18 | Arrow Alexander K. Chief Financial Officer | Grant or award · PTIX Common stock Options | +124,998 | $1.75 | $219K | 124,998 |
| 2020-02-21 | Stein Robert Benjamin Director | Grant or award · PTIX Common stock Options | +150,000 | 150,000 | ||
| 2020-02-21 | Barrage Khalil Director | Grant or award · PTIX Common stock Options | +120,000 | 120,000 | ||
| 2020-02-21 | Silverman Joshua Director | Grant or award · PTIX Common stock Options | +120,000 | 120,000 | ||
| 2020-02-21 | ARMEN GARO H Executive Chairman | Grant or award · PTIX Common stock Options | +300,000 | 300,000 | ||
| 2020-02-21 | Corvese Brian Director | Grant or award · PTIX Common stock Options | +120,000 | 120,000 |
Page 2 of 10 · 196 trades